Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning

Standard

Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning. / Klauschen, F; Müller, Klaus-Robert; Binder, A; Bockmayr, M; Hägele, M; Seegerer, P; Wienert, S; Pruneri, G; de Maria, S; Badve, S; Michiels, S; Nielsen, T O; Adams, S; Savas, P; Symmans, F; Willis, S; Gruosso, T; Park, M; Haibe-Kains, B; Gallas, B; Thompson, A M; Cree, I; Sotiriou, C; Solinas, C; Preusser, M; Hewitt, S M; Rimm, D; Viale, G; Loi, S; Loibl, S; Salgado, R; Denkert, C; International Immuno-Oncology Biomarker Working Group.

in: SEMIN CANCER BIOL, Jahrgang 52, Nr. Pt 2, 10.2018, S. 151-157.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

Klauschen, F, Müller, K-R, Binder, A, Bockmayr, M, Hägele, M, Seegerer, P, Wienert, S, Pruneri, G, de Maria, S, Badve, S, Michiels, S, Nielsen, TO, Adams, S, Savas, P, Symmans, F, Willis, S, Gruosso, T, Park, M, Haibe-Kains, B, Gallas, B, Thompson, AM, Cree, I, Sotiriou, C, Solinas, C, Preusser, M, Hewitt, SM, Rimm, D, Viale, G, Loi, S, Loibl, S, Salgado, R, Denkert, C & International Immuno-Oncology Biomarker Working Group 2018, 'Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning', SEMIN CANCER BIOL, Jg. 52, Nr. Pt 2, S. 151-157. https://doi.org/10.1016/j.semcancer.2018.07.001

APA

Klauschen, F., Müller, K-R., Binder, A., Bockmayr, M., Hägele, M., Seegerer, P., Wienert, S., Pruneri, G., de Maria, S., Badve, S., Michiels, S., Nielsen, T. O., Adams, S., Savas, P., Symmans, F., Willis, S., Gruosso, T., Park, M., Haibe-Kains, B., ... International Immuno-Oncology Biomarker Working Group (2018). Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning. SEMIN CANCER BIOL, 52(Pt 2), 151-157. https://doi.org/10.1016/j.semcancer.2018.07.001

Vancouver

Bibtex

@article{ae0227cfb15943b7a63770e91aaf99b9,
title = "Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning",
abstract = "The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-mutational burden and other biomarkers, has been demonstrated to be a marker of response to immune-checkpoint therapy in several cancers. Pathologists have therefore started to devise standardized visual approaches to quantify TILs for therapy prediction. However, despite successful standardization efforts visual TIL estimation is slow, with limited precision and lacks the ability to evaluate more complex properties such as TIL distribution patterns. Therefore, computational image analysis approaches are needed to provide standardized and efficient TIL quantification. Here, we discuss different automated TIL scoring approaches ranging from classical image segmentation, where cell boundaries are identified and the resulting objects classified according to shape properties, to machine learning-based approaches that directly classify cells without segmentation but rely on large amounts of training data. In contrast to conventional machine learning (ML) approaches that are often criticized for their {"}black-box{"} characteristics, we also discuss explainable machine learning. Such approaches render ML results interpretable and explain the computational decision-making process through high-resolution heatmaps that highlight TILs and cancer cells and therefore allow for quantification and plausibility checks in biomedical research and diagnostics.",
keywords = "Journal Article, Review",
author = "F Klauschen and Klaus-Robert M{\"u}ller and A Binder and M Bockmayr and M H{\"a}gele and P Seegerer and S Wienert and G Pruneri and {de Maria}, S and S Badve and S Michiels and Nielsen, {T O} and S Adams and P Savas and F Symmans and S Willis and T Gruosso and M Park and B Haibe-Kains and B Gallas and Thompson, {A M} and I Cree and C Sotiriou and C Solinas and M Preusser and Hewitt, {S M} and D Rimm and G Viale and S Loi and S Loibl and R Salgado and C Denkert and {International Immuno-Oncology Biomarker Working Group}",
note = "Copyright {\textcopyright} 2018. Published by Elsevier Ltd.",
year = "2018",
month = oct,
doi = "10.1016/j.semcancer.2018.07.001",
language = "English",
volume = "52",
pages = "151--157",
journal = "SEMIN CANCER BIOL",
issn = "1044-579X",
publisher = "Academic Press Inc.",
number = "Pt 2",

}

RIS

TY - JOUR

T1 - Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning

AU - Klauschen, F

AU - Müller, Klaus-Robert

AU - Binder, A

AU - Bockmayr, M

AU - Hägele, M

AU - Seegerer, P

AU - Wienert, S

AU - Pruneri, G

AU - de Maria, S

AU - Badve, S

AU - Michiels, S

AU - Nielsen, T O

AU - Adams, S

AU - Savas, P

AU - Symmans, F

AU - Willis, S

AU - Gruosso, T

AU - Park, M

AU - Haibe-Kains, B

AU - Gallas, B

AU - Thompson, A M

AU - Cree, I

AU - Sotiriou, C

AU - Solinas, C

AU - Preusser, M

AU - Hewitt, S M

AU - Rimm, D

AU - Viale, G

AU - Loi, S

AU - Loibl, S

AU - Salgado, R

AU - Denkert, C

AU - International Immuno-Oncology Biomarker Working Group

N1 - Copyright © 2018. Published by Elsevier Ltd.

PY - 2018/10

Y1 - 2018/10

N2 - The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-mutational burden and other biomarkers, has been demonstrated to be a marker of response to immune-checkpoint therapy in several cancers. Pathologists have therefore started to devise standardized visual approaches to quantify TILs for therapy prediction. However, despite successful standardization efforts visual TIL estimation is slow, with limited precision and lacks the ability to evaluate more complex properties such as TIL distribution patterns. Therefore, computational image analysis approaches are needed to provide standardized and efficient TIL quantification. Here, we discuss different automated TIL scoring approaches ranging from classical image segmentation, where cell boundaries are identified and the resulting objects classified according to shape properties, to machine learning-based approaches that directly classify cells without segmentation but rely on large amounts of training data. In contrast to conventional machine learning (ML) approaches that are often criticized for their "black-box" characteristics, we also discuss explainable machine learning. Such approaches render ML results interpretable and explain the computational decision-making process through high-resolution heatmaps that highlight TILs and cancer cells and therefore allow for quantification and plausibility checks in biomedical research and diagnostics.

AB - The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-mutational burden and other biomarkers, has been demonstrated to be a marker of response to immune-checkpoint therapy in several cancers. Pathologists have therefore started to devise standardized visual approaches to quantify TILs for therapy prediction. However, despite successful standardization efforts visual TIL estimation is slow, with limited precision and lacks the ability to evaluate more complex properties such as TIL distribution patterns. Therefore, computational image analysis approaches are needed to provide standardized and efficient TIL quantification. Here, we discuss different automated TIL scoring approaches ranging from classical image segmentation, where cell boundaries are identified and the resulting objects classified according to shape properties, to machine learning-based approaches that directly classify cells without segmentation but rely on large amounts of training data. In contrast to conventional machine learning (ML) approaches that are often criticized for their "black-box" characteristics, we also discuss explainable machine learning. Such approaches render ML results interpretable and explain the computational decision-making process through high-resolution heatmaps that highlight TILs and cancer cells and therefore allow for quantification and plausibility checks in biomedical research and diagnostics.

KW - Journal Article

KW - Review

U2 - 10.1016/j.semcancer.2018.07.001

DO - 10.1016/j.semcancer.2018.07.001

M3 - SCORING: Review article

C2 - 29990622

VL - 52

SP - 151

EP - 157

JO - SEMIN CANCER BIOL

JF - SEMIN CANCER BIOL

SN - 1044-579X

IS - Pt 2

ER -